Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS

Executive Summary

The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans

You may also be interested in...



Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal

The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9

Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal

The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9

Pharma Gets A Friendly Bill: Proposal Would Cut Medicare Rx Copays

A bill being sponsored by Sen. Kay Hutchison, R-Tex., aims to demonstrate that reducing Medicare beneficiaries' cost sharing for prescriptions will increase their adherence to medication therapy

Related Content

Topics

UsernamePublicRestriction

Register

PS050860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel